Article ID Journal Published Year Pages File Type
2971757 The Journal of Heart and Lung Transplantation 2011 8 Pages PDF
Abstract
Disease etiology, baseline factors (NYHA FC, PVRI and SVO2) and on-treatment factors (6MWD, SVO2 and treprostinil dose) were predictors of survival in this study and may be used to aid in treatment optimization.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
Authors
, , , , , , ,